ConductScience.org, home

Paper2376572

Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver.

Deguchi T and 2 others. J Biol Chem, 1990. Cited by 177 papers, by iCite.

Cite this record

ConductScience Library. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. Papers, record 2376572. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2376572

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver.
PubMed
Journal
J Biol Chem
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
177
iCite
Relative citation ratio, by iCite
6.66
iCite
Revised in PubMed
2021-02-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Deguchi TT
2Mashimo MM
3Suzuki TT

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetyltransferasesMajor topic
Arylamine N-AcetyltransferaseMajor topic
LiverMajor topic
Blotting, Southern
DNA
Genotype
Humans
Leukocytes
Phenotype
Polymorphism, Genetic
Restriction Mapping

Source PubMed

Download CSV of topics

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 177 citations.

PMIDTitleJournalYearIn PapersSource
39720855The N-Acetyltransferase 2 Polymorphism and Susceptibility to Inflammatory Bowel Disease: A Case-Control Study.Pharmacol Res Perspect2025https://conductscience.org/library/papers/39720855PubMed
35928262Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population.Front Pharmacol2022https://conductscience.org/library/papers/35928262PubMed
34452561Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.Asian Pac J Cancer Prev2021https://conductscience.org/library/papers/34452561PubMed
32927458Genotype-Guided Hydralazine Therapy.Am J Nephrol2020https://conductscience.org/library/papers/32927458PubMed
32372066Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes.Sci Rep2020https://conductscience.org/library/papers/32372066PubMed
31964788N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/31964788PubMed
31285712Determination of Arylamine N-Acetyltransferase 2 Acetylation Genotype by PCR and Phenotyping Using Dapsone Through High-Pressure Liquid Chromatography Assay: A Gender Wise Study.Dose Response2019https://conductscience.org/library/papers/31285712PubMed
25163630Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.Mol Biol Rep2014https://conductscience.org/library/papers/25163630PubMed
24467436Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.Br J Pharmacol2014https://conductscience.org/library/papers/24467436PubMed
23053951Study of NAT2 genetic polymorphism in West African subjects: example of an healthy non-smoker Senegalese population.Mol Biol Rep2012https://conductscience.org/library/papers/23053951PubMed
22092036Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.Pharmacogenomics2012https://conductscience.org/library/papers/22092036PubMed
21432481N-Acetyltransferase polymorphism and human cancer risk.Environ Health Prev Med2000https://conductscience.org/library/papers/21432481PubMed
20430842Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.J Pharmacol Exp Ther2010https://conductscience.org/library/papers/20430842PubMed
20099048A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.Med Oncol2011https://conductscience.org/library/papers/20099048PubMed
19350634Effects of dietary factors and the NAT2 acetylator status on gastric cancer in Koreans.Int J Cancer2009https://conductscience.org/library/papers/19350634PubMed
18023090NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis.World J Gastroenterol2007https://conductscience.org/library/papers/18023090PubMed
17665185Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2.Eur J Clin Pharmacol2007https://conductscience.org/library/papers/17665185PubMed
17377643N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.Can J Gastroenterol2007https://conductscience.org/library/papers/17377643PubMed
16570187The influence of various genotypes on the metabolic activity of NAT2 in a Chinese population.Eur J Clin Pharmacol2006https://conductscience.org/library/papers/16570187PubMed
16550165N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.Oncogene2006https://conductscience.org/library/papers/16550165PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2376572

GET https://conductscience.org/api/papers/v1/2376572/cited_by?page=2